Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Repetin is a protein involved in skin and hair development, binding calcium and compensating for other proteins when needed.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

A specific thyroid hormone resistance mutation may be linked to different types of hair loss.

A novel CLDN1 mutation in a 2-month-old with NISCH showed improvement with symptom management.

A 2-year-old boy was diagnosed with a rare genetic condition causing fragile hair, intellectual issues, and short stature.

Steroid pulse therapy improved symptoms in a man with Satoyoshi syndrome.

A 13-year-old girl with various symptoms was successfully treated for autoimmune disease using the antibiotic co-trimoxazole.

Alitretinoin may help treat alopecia areata.

Trichoscopy is a helpful tool for diagnosing Netherton syndrome.

Ritlecitinib can reduce inflammation and help hair regrow in Alopecia Areata.

Netherton syndrome can cause severe and chronic vulvovaginal symptoms that may improve with continuous oral contraceptives.

Eating Citrullus colocynthis can cause severe intestinal bleeding and damage.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

The horse had a rare disease causing weight loss and skin issues, leading to euthanasia due to poor treatment options.

A child with trichothiodystrophy also had autoimmune thyroiditis and anemia, which is a new finding.

The man's diarrhea was caused by a rare disorder called Cronkhite-Canada syndrome, which improved with specific medications.

A 20-year-old woman with a rare form of Turner syndrome showed improvement with hormonal therapy and needs comprehensive care.

A 60-year-old man with Cronkhite-Canada syndrome improved with treatment, but the condition has a high mortality rate and a risk of colorectal cancer.

A child with Olmsted syndrome showed mild improvement in hair and skin issues with treatment.

Rituximab improved her dermatomyositis better than usual treatments.

Individualized treatment and support can help most couples with recurrent implantation failure achieve pregnancy.

A young woman with visual issues and other symptoms was diagnosed with lupus and antiphospholipid syndrome, and improved with treatment.

Children's Serum Sickness-Like Reaction is often linked to antibiotics, especially amoxicillin, and involves symptoms like rash, fever, and joint issues.

Zinc treatment improved skin and hair issues in a boy with a zinc-related condition.

A woman with both Cronkhite-Canada syndrome and myelodysplastic syndrome improved significantly with corticosteroid treatment.

Changes in the SREBF1 gene cause a rare genetic skin and hair disorder.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Regular endoscopic checks are crucial for Cronkhite-Canada syndrome patients to catch potential cancers early.